• Presentation: 12Jun2018 17:30  Identification of Optimal Subcutaneous Dose of Tocilizumab in Children with Systemic Juvenile Idiopathic Arthritis. Abstract number: OP0103. 


  • Presentation: 14Jun2018 12:20  Absence of association between drug exposure and infection in patients with polyarticular-course juvenile idiopathic arthritis and adequate response to biologic or non-biologic DMARDS treated with SC and IV abatacept.  Abstract number: THU0549.



March 2017 - Subcutaneous abatacept now available for patients with JIA. link


January 19, 2017 - HHS released revisions to the Common Rule aimed to enhance protections for research participants.


January 18, 2017 - New NIH Policy goes into effect: Dissemination of NIH-Funded Clinical Trial Information.


November 2016 - ICH released revised Guideline for Good Clinical Practice: ICH GCP E6(R2)